Cargando…

IDO/kynurenine pathway in cancer: possible therapeutic approaches

Cancer is one of the leading causes of death in both men and women worldwide. One of the main changes associated with cancer progression, metastasis, recurrence, and chemoresistance is the change in the tumor immune microenvironment, especially immunosuppression. Cancer immunosuppression appears in...

Descripción completa

Detalles Bibliográficos
Autor principal:	Abd El-Fattah, Eslam E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9344609/ https://www.ncbi.nlm.nih.gov/pubmed/35918736 http://dx.doi.org/10.1186/s12967-022-03554-w

Ejemplares similares

Interactions of IDO and the Kynurenine Pathway with Cell Transduction Systems and Metabolism at the Inflammation–Cancer Interface
por: Stone, Trevor W., et al.
Publicado: (2023)

IDO and Kynurenine Metabolites in Peripheral and CNS Disorders
por: Huang, Yi-Shu, et al.
Publicado: (2020)

Reversal of IDO-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
por: Triplett, Todd A., et al.
Publicado: (2018)

Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management
por: Abd El-Fattah, Eslam E., et al.
Publicado: (2022)

Hypoxic preconditioning protects against ischemic kidney injury through the IDO1/kynurenine pathway
por: Torosyan, Rafael, et al.
Publicado: (2021)

The immunomodulatory role of IDO1-Kynurenine-NAD(+) pathway in switching cold tumor microenvironment in PDAC
por: Anu, R. I., et al.
Publicado: (2023)

DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota
por: Zhao, Li-Ping, et al.
Publicado: (2023)

Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression
por: Heng, Benjamin, et al.
Publicado: (2020)

The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022)

Hypoxia and the Kynurenine Pathway: Implications and Therapeutic Prospects in Alzheimer's Disease
por: Adeyemi, Oluyomi Stephen, et al.
Publicado: (2021)

The tryptophan–kynurenine pathway in immunomodulation and cancer metastasis
por: Basson, Charlise, et al.
Publicado: (2023)

Kynurenine pathway in kidney diseases
por: Zakrocka, Izabela, et al.
Publicado: (2021)

Inhibiting the kynurenine pathway in spinal cord injury: multiple therapeutic potentials?
por: Jacobs, Kelly R., et al.
Publicado: (2018)

Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations
por: Muneer, Ather
Publicado: (2020)

Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
por: Mithaiwala, Mustafa N., et al.
Publicado: (2021)

Role of IDO and TDO in Cancers and Related Diseases and the Therapeutic Implications
por: Ye, Zixiang, et al.
Publicado: (2019)

Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance
por: Zhang, Xin, et al.
Publicado: (2021)

Targeting the IDO1 pathway in cancer: from bench to bedside
por: Liu, Ming, et al.
Publicado: (2018)

Inhibition of the BET family reduces its new target gene IDO1 expression and the production of l-kynurenine
por: Tian, Chang-Qing, et al.
Publicado: (2019)

Human Indoleamine 2,3-dioxygenase 1 (IDO1) Expressed in Plant Cells Induces Kynurenine Production
por: Bellucci, Michele, et al.
Publicado: (2021)

Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis
por: Williams, Richard O.
Publicado: (2013)

The Footprint of Kynurenine Pathway in Cardiovascular Diseases
por: Ala, Moein, et al.
Publicado: (2022)

The Kynurenine Pathway in Stem Cell Biology
por: Jones, Simon P., et al.
Publicado: (2013)

Involvement of Kynurenine Pathway in Hepatocellular Carcinoma
por: Krishnamurthy, Shivani, et al.
Publicado: (2021)

Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
por: Bohár, Zsuzsanna, et al.
Publicado: (2015)

Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
por: Biernacki, Tamás, et al.
Publicado: (2020)

The Footprint of Kynurenine Pathway in Neurodegeneration: Janus-Faced Role in Parkinson’s Disorder and Therapeutic Implications
por: Behl, Tapan, et al.
Publicado: (2021)

Kynurenine pathway metabolism and neuroinflammatory disease
por: Braidy, Nady, et al.
Publicado: (2017)

Kynurenine pathway in Parkinson's disease—An update
por: Venkatesan, Dhivya, et al.
Publicado: (2020)

Understanding the role of the kynurenine pathway in human breast cancer immunobiology
por: Heng, Benjamin, et al.
Publicado: (2015)

Inflammation in cancer and depression: a starring role for the kynurenine pathway
por: Sforzini, Luca, et al.
Publicado: (2019)

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
por: Phillips, Robert S., et al.
Publicado: (2019)

Kynurenine Pathway in Psoriasis—a Promising Link?
por: Stepaniuk, A., et al.
Publicado: (2023)

Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs
por: Volarevic, Vladislav, et al.
Publicado: (2019)

Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells
por: Liu, Yuying, et al.
Publicado: (2017)

The Role of the Kynurenine Signaling Pathway in Different Chronic Pain Conditions and Potential Use of Therapeutic Agents
por: Jovanovic, Filip, et al.
Publicado: (2020)

Imbalanced Kynurenine Pathway in Schizophrenia
por: Kegel, Magdalena E, et al.
Publicado: (2014)

Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease
por: Liang, Yuqing, et al.
Publicado: (2022)

The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
por: Zinger, Anna, et al.
Publicado: (2011)

Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
por: Tanaka, Masaru, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_95kgs7ocq64p8h13hguqjt29lp